Article Details

Bristol-Myers, NEA drive cancer test player to $75M round

Retrieved on: 2018-01-03 22:37:30

Tags for this article:

Click the tags to see associated articles and topics

Bristol-Myers, NEA drive cancer test player to $75M round. View article details on hiswai:

Excerpt

<div>Bristol-Myers Squibb and <b>New Enterprise Associates</b> (NEA) have co-led a $75 million investment in Personal Genome Diagnostics (PGDx). The series B gives PGDx the means to pursue approvals of its tissue and liquid biopsy IVD cancer tests in markets around the world. PGDx has rolled out a range of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up